Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Ratain

Showing results (21-30 of 225) with videos related to

Pageof 23
Sort By:
Clinical Pharmacology and Therapeutics|January 11, 2017
Food Effect Studies for Oncology Drug ProductsS Parsad, M J Ratain
Cancer Chemotherapy and Pharmacology|September 28, 1998
Clinical pharmacology of camptothecinsL Iyer, M J Ratain
Seminars in Oncology|April 1, 1997
New phase I trial methodologyS Mani, M J Ratain
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genesM J Ratain, J D Rowley
British Journal of Cancer|December 14, 2006
Evaluating the activity of temsirolimus in neuroendocrine cancerP H O'Donnell, M J Ratain
Cancer Research|March 15, 1991
Correspondence re: Xiu F. Hu et al., Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines. Cancer Res., 50: 2953-2957, 1990B L Samuels, M J Ratain
Clinical Pharmacology and Therapeutics|November 18, 2014
Meaningful use of pharmacogeneticsM J Ratain, J A Johnson
The New England Journal of Medicine|March 31, 2001
Conflict-of-interest policiesM J Ratain, M E Sheridan
Clinical Pharmacology and Therapeutics|January 24, 2013
Playing Russian roulette with tyrosine kinase inhibitorsR Z Szmulewitz, M J Ratain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Oral chemotherapy: rationale and future directionsM D DeMario, M J Ratain
Pageof 23

Showing results (21-30 of 225) with videos related to

Sort By:
Pageof 23
Clinical Pharmacology and Therapeutics|January 11, 2017
Food Effect Studies for Oncology Drug ProductsS Parsad, M J Ratain
Cancer Chemotherapy and Pharmacology|September 28, 1998
Clinical pharmacology of camptothecinsL Iyer, M J Ratain
Seminars in Oncology|April 1, 1997
New phase I trial methodologyS Mani, M J Ratain
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genesM J Ratain, J D Rowley
British Journal of Cancer|December 14, 2006
Evaluating the activity of temsirolimus in neuroendocrine cancerP H O'Donnell, M J Ratain
Cancer Research|March 15, 1991
Correspondence re: Xiu F. Hu et al., Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines. Cancer Res., 50: 2953-2957, 1990B L Samuels, M J Ratain
Clinical Pharmacology and Therapeutics|November 18, 2014
Meaningful use of pharmacogeneticsM J Ratain, J A Johnson
The New England Journal of Medicine|March 31, 2001
Conflict-of-interest policiesM J Ratain, M E Sheridan
Clinical Pharmacology and Therapeutics|January 24, 2013
Playing Russian roulette with tyrosine kinase inhibitorsR Z Szmulewitz, M J Ratain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Oral chemotherapy: rationale and future directionsM D DeMario, M J Ratain
Pageof 23